glp-1 manufacturers in usa Lilly to pour $6.5 billion into pill manufacturing site 2025’s Breakthrough GLP-1 Obesity Treatments:

Does United Healthcare cover Wegovy for weight loss

Study results: what did they find

Learn how low-dose semaglutide and tirzepatide may support metabolism, menopause, inflammation, and autoimmune health.

In these cardiovascular safety trials, in secondary or exploratory analyses, GLP-1 receptor agonists were also shown to reduce macro-albuminuria, an accepted surrogate marker for diabetic kidney disease (DKD), a condition that still represents a major unmet medical need

Employers can't shirk responsibility for novel weight loss drugs forever, executives argued at a recent Newsweek event.

As a health coach, I compare these two popular telehealth options to help you decide.